Autoantibodies occur in many different nervous system disorders, and are increasingly being found in disorders not traditionally associated with the immune system. Determining if the autoantibodies play a functional or pathogenic role is critical in selecting the most appropriate treatment options.
Milan Fiala and Matteo Pellegrini review current research that indicates a role for omega-3 fatty acids in slowing the progression of mild cognitive impairment.
Researchers at Colombia University, New York (NY, USA), have recently demonstrated that tau pathology induces dysfunction in cells specifically tuned to compute spatial information.
Dr Paul Gallagher (Institute of Neurological Sciences, Glasgow, UK) provides an overview of these two recent papers by Jokubaitis and colleagues  and Cree and colleagues, which both assessed factors predictive of long-term disability outcomes in people with multiple sclerosis (MS).
A systemic immune network involving benign autoimmune T cells supports brain maintenance, function and repair, and could be boosted in a well-controlled manner for therapy of brain pathologies.
David Howett reviews a recent Lancet article that indicated that proximity to heavy traffic is associated with a higher incidence of dementia.
David Howett reviews a recent paper from Hefendehl et al. that reported that the microenvironment surrounding amyloid plaques disrupts neuronal glutamate homeostasis
Lauren Pulling highlights some of the key trending topics in neurology and neuroscience from 2016, as well as the top read articles of the year – take a look and let us know your thoughts.
Journal Watch columnist David Howett reviews the recent paper ‘Complement biomarkers as predictors of disease progression in Alzheimer’s disease’ and what its findings could mean for the future of Alzheimer’s disease diagnostics.
David Burn, Clinical Director of Parkinson’s UK, discusses the results of the 2015 UK Parkinson’s Audit, which concerns the quality of Parkinson’s disease care provided in the UK.